Welcome to the UPF Digital Repository
Browsing by Author "Camps-Vilaró, Anna"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Camps-Vilaró, Anna"
Now showing items 1-8 of 8
-
Dégano, Irene R.; Camps-Vilaró, Anna; Subirana Cachinero, Isaac; García-Mateo, Nadia; Cidad, Pilar; Muñoz Aguayo, Daniel; Puigdecanet Riubugent, Eulàlia; Nonell Mazelón, Lara; Vila, Joan; Crepaldi, Felipe M.; Gonzalo-Calvo, David de; Llorente-Cortés, Vicenta; Pérez García, María Teresa; Elosua Llanos, Roberto; Fitó Colomer, Montserrat; Marrugat de la Iglesia, Jaume (MDPI, 2020)Risk prediction tools cannot identify most individuals at high coronary artery disease (CAD) risk. Oxidized low-density lipoproteins (oxLDLs) and microRNAs are actively involved in atherosclerosis. Our aim was to examine ...
-
Maragaño Lizama, Patricio; Ríos, Diana L.; Subirana Cachinero, Isaac; Toloba, Andrea; Camps-Vilaró, Anna; Belzares, Oward; Pacheco, Claudio; Cerro, Cristina; Wehinger, Sergio; Fuentes, Eduardo; Marrugat de la Iglesia, Jaume; Palomo, Iván (MDPI, 2021)The present study aimed to determine the relationship between the prevalence of cardiovascular risk factors and the number and severity of coronary artery atherosclerotic lesions obtained by coronary angiography. We reviewed ...
-
Subirana Cachinero, Isaac; Camps-Vilaró, Anna; Elosua Llanos, Roberto; Marrugat de la Iglesia, Jaume; Tizón-Marcos, Helena; Palomo, Iván; Dégano, Irene R. (Dove Medical Press, 2022)Background and aims: cardiovascular (CV) risk functions are the recommended tool to identify high-risk individuals. However, their discrimination ability is not optimal. While the effect of biomarkers in CV risk prediction ...
-
Camps-Vilaró, Anna; Delgado-Jiménez, Juan F.; Farré López, Núria; Tizón-Marcos, Helena; Álvarez-García, Jesus; Cinca, Juan; Dégano, Irene R.; Marrugat de la Iglesia, Jaume (MDPI, 2020)Heart failure (HF) is one of the main causes of morbidity, mortality, and high healthcare costs. Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced cardiovascular mortality and hospitalization for ...
-
Marrugat de la Iglesia, Jaume; Camps-Vilaró, Anna; Tizón-Marcos, Helena (Elsevier, 2021)
-
Tizón-Marcos, Helena; Vaquerizo Montilla, Beatriz; Mauri, Josepa; Farré López, Núria; Lidón, Rosa-Maria; Garcia-Picart, Joan; Regueiro, Ander; Ariza, Albert; Carrillo, Xavier; Duran, Xavier; Poirier, Paul; Cladellas Capdevila, M.Mercedes; Camps-Vilaró, Anna; Ribas Barquet, Núria; Cubero Gallego, Héctor; Marrugat de la Iglesia, Jaume (Frontiers, 2022)Background: despite the spread of ST-elevation myocardial infarction (STEMI) emergency intervention networks, inequalities in healthcare access still have a negative impact on cardiovascular prognosis. The Family Income ...
-
Camps-Vilaró, Anna; Pérez-Fernández, Silvia; Subirana Cachinero, Isaac; Teira, Ramón; Estrada, Vicente; Domingo, Pere; Dégano, Irene R.; Marrugat de la Iglesia, Jaume (MDPI, 2021)People living with HIV (PLWH) have an increased risk of cardiovascular (CV) disease, likely due to a higher prevalence of CV risk factors. We compared the age-standardized prevalence and management of CV risk factors in ...
-
Viladés-Medel, David; Dégano, Irene R.; Subirana Cachinero, Isaac; Descalzo, Martin; Padilla, Mireia; Mundet-Tudurí, Xavier; Carreras Costa, Francesc; Alomar Serrallach, Xavier; Camps-Vilaró, Anna; Elosua Llanos, Roberto; Marrugat de la Iglesia, Jaume; Leta Petracca, Rubén (MDPI, 2022)Accurate identification of individuals at high coronary risk would reduce acute coronary syndrome incidence and morbi-mortality. We analyzed the effect on coronary risk prediction of adding coronary artery calcification ...
Now showing items 1-8 of 8
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00